CD4 and neoplasm: Our study identified differences in tumor infiltrating cells between high-risk and low-risk groups according to an immune-related lncRNA model, focusing on cells including dendritic cells, B cells, CD4 T cells, CD8 T cells, Natural killer cells, T follicular helper cells, and mast cells.